P1-34 (book/static) Question Help Chris Jackson was recently promoted to Controller of Research and Development (R&D) for BrisCor, a Fortune 500 pharmaceutical company that manufactures prescription drugs and nutritional supplements. (Click the icon to view more information.) Jackson came up with the following ideas for making the third-quarter budgeted targets: (Click the icon to view the ideas.) Read the requirements The "Standards of Ethical Behavior for Practitioners of Management Accounting and Financial Management" require management accountants to: (Select all that apply.) A. Do not disclose delays or deficiencies in information, timeliness, processing, or internal controls due to organization policy. B. Perform professional duties in accordance with relevant laws, regulations, and technical standards. C. Refrain from engaging in any conduct that would prejudice carrying out duties ethically. D. Disclose confidential information when it is requested by anyone. RE Communicate information fairly and objectively. VE Disclose all relevant information that could reasonably be expected to influence an intended user's understanding of the reports, analyses, or recommendations. G. Occasionally communicate with business associates to resolve apparent conflicts of interest. Determine whether each of the proposed ideas is in clear violation (Violation), is clearly in compliance with (No Violation), or may be in violation with (Potential Violation) the "Standards of Ethical Behavior for Practitioners of Management Accounting and Financial Management". Proposed Idea Violation? Stop all research and development efforts on the drug Vyacon until after year-end. This change would delay the drug going to market by at least 6 months. It is possible that in the meantime a BrisCor competitor could make it to market with a similar drug. a. Choose from any drop-down list and then click Check Answer. ? No Violation Potential Violation Violation parts remaining Clear All Check